TFF Pharmaceuticals, Inc.
TFFPDelisted Mar 6, 2025- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001733413
TFF Pharmaceuticals, Inc. was delisted on Mar 6, 2025; its insiders filed their last Form 4 on Jul 8, 2024; 23 institutions reported holding it in 13F filings for Q3 2024, worth $1.48M in total; no superinvestor held it.
Holders of 5% or more of TFFP
Holders whose latest Schedule 13D or 13G filing reports 5% or more of TFF Pharmaceuticals, Inc., largest stake first. The change is against the holder's previous filing.
No holder currently reports owning 5% or more of TFF Pharmaceuticals, Inc. on Schedule 13D or 13G.
Stakes are as of each holder's latest filing. Holders whose last filing was in the old format (before December 18, 2024) have no stake on record and are not listed, and after an acquisition or delisting holders usually stop filing.
13D and 13G filings
3 Schedule 13D and 13G filings on TFF Pharmaceuticals, Inc., newest first, including old-format filings without a stake.
| Filed (ET) | Filer | Form | Stake | Change | Event date | Filing |
|---|---|---|---|---|---|---|
| Feb 14, 2023 | Lung Therapeutics, Inc. | 13G/AOld format | – | – | – | SEC |
| Feb 13, 2023 | Lytton Laurence W | 13G/AOld format | – | – | – | SEC |
| Feb 9, 2023 | Carlson Capital L P | 13G/AOld format | – | – | – | SEC |
| Nov 28, 2022 | Carlson Capital L P | 13GOld format | – | New | – | SEC |
| Nov 23, 2022 | Lytton Laurence W | 13GOld format | – | New | – | SEC |
| Feb 14, 2022 | Lung Therapeutics, Inc. | 13G/AOld format | – | – | – | SEC |
| Feb 14, 2022 | Corriente Advisors, LLC | 13G/AOld format | – | – | – | SEC |
| Feb 14, 2022 | Nantahala Capital Management, LLC | 13G/AOld format | – | – | – | SEC |
| Feb 16, 2021 | Corriente Advisors, LLC | 13GOld format | – | New | – | SEC |
| Feb 16, 2021 | Nantahala Capital Management, LLC | 13GOld format | – | New | – | SEC |
| Feb 3, 2021 | Lung Therapeutics, Inc. | 13G/AOld format | – | – | – | SEC |
Form 144: proposed insider sales
Notices from officers, directors and other affiliates planning to sell TFF Pharmaceuticals, Inc. shares.
No Form 144 notices for TFF Pharmaceuticals, Inc. are on file.